{
    "Trade/Device Name(s)": [
        "Dimension Vista HbA1c Kit",
        "Dimension Vista HbA1c",
        "Dimension Vista HA1C Kit"
    ],
    "Submitter Information": "Siemens Healthcare Diagnostics Inc",
    "510(k) Number": "K102045",
    "Predicate Device Reference 510(k) Number(s)": [
        "K062128"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LCP",
        "JIT"
    ],
    "Summary Letter Date": "January 14, 2011",
    "Summary Letter Received Date": "January 18, 2011",
    "Submission Date": "November 9, 2010",
    "Regulation Number(s)": [
        "21 CFR 864.7470"
    ],
    "Regulation Name(s)": [
        "Glycosylated Hemoglobin Assay"
    ],
    "Analyte Class(es)": [
        "hematology"
    ],
    "Analyte(s)": [
        "Hemoglobin A1c",
        "Total Hemoglobin"
    ],
    "Specimen Type(s)": [
        "Anticoagulated whole blood"
    ],
    "Specimen Container(s)": [
        "EDTA tube"
    ],
    "Instrument(s)/Platform(s)": [
        "Dimension Vista System"
    ],
    "Method(s)/Technology(ies)": [
        "Turbidometric inhibition immunoassay (TINIA)",
        "Alkaline hematin reaction (modified)"
    ],
    "Methodologies": [
        "Immunoassay",
        "Quantitative measurement"
    ],
    "Submission Type(s)": [
        "Kit",
        "Calibrator",
        "Reagent cartridge"
    ],
    "Document Summary": "FDA 510(k) summary for Dimension Vista HbA1c kit for quantitative determination of hemoglobin A1c in anticoagulated whole blood using turbidometric inhibition immunoassay on Dimension Vista System.",
    "Indications for Use Summary": "In vitro diagnostic assay for quantitative determination of percent Hemoglobin A1c in human anticoagulated whole blood to monitor long term glucose control in individuals with diabetes mellitus.",
    "fda_folder": "Hematology"
}